119 related articles for article (PubMed ID: 22981726)
1. Characterizing hepatocellular carcinoma using multi-breath-hold two-dimensional susceptibility-weighted imaging: comparison to conventional liver MRI.
Tao R; Zhang J; Dai Y; You Z; Fan Y; Cui J; Wang J
Clin Radiol; 2012 Dec; 67(12):e91-7. PubMed ID: 22981726
[TBL] [Abstract][Full Text] [Related]
2. Using a 2D multibreath-hold susceptibility-weighted imaging to visualize intratumoral hemorrhage of hepatocellular carcinoma at 3T MRI: correlation with pathology.
Li RK; Zeng MS; Rao SX; Qiang JW; Dai YM; Ji Y; Chen CZ; Renate J
J Magn Reson Imaging; 2012 Oct; 36(4):900-6. PubMed ID: 22744981
[TBL] [Abstract][Full Text] [Related]
3. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
[TBL] [Abstract][Full Text] [Related]
4. Detection of siderotic nodules in the liver with susceptibility weighted imaging: correlations to serum ferritin, Child-Pugh grade and hyaluronic acid levels.
Tao R; You ZL; Zhang JQ; Dai YM; Zhou DQ; Cai P; Fan Y; Cui JG; Wang J
Chin Med J (Engl); 2012 Sep; 125(17):3110-4. PubMed ID: 22932190
[TBL] [Abstract][Full Text] [Related]
5. Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity.
Rosenkrantz AB; Lee L; Matza BW; Kim S
Clin Radiol; 2012 Dec; 67(12):e105-11. PubMed ID: 23026725
[TBL] [Abstract][Full Text] [Related]
6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
7. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
8. Improving detection of siderotic nodules in cirrhotic liver with a multi-breath-hold susceptibility-weighted imaging technique.
Dai Y; Zeng M; Li R; Rao S; Chen C; DelProposto Z; Haacke EM; Hu J; Renate J
J Magn Reson Imaging; 2011 Aug; 34(2):318-25. PubMed ID: 21780226
[TBL] [Abstract][Full Text] [Related]
9. Characterizing venous vasculatures of hepatocellular carcinoma using a multi-breath-hold two-dimensional susceptibility weighted imaging.
Chang SX; Li GW; Chen Y; Bao H; Zhou L; Yuan J; Wu DM; Dai YM
PLoS One; 2013; 8(6):e65895. PubMed ID: 23799060
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility-weighted imaging: the value in cerebral astrocytomas grading.
Zhang H; Tan Y; Wang XC; Qing JB; Wang L; Wu XF; Zhang L; Liu QW
Neurol India; 2013; 61(4):389-95. PubMed ID: 24005730
[TBL] [Abstract][Full Text] [Related]
11. Detection of tumour boundary in metastatic liver disease with 2D multibreath-hold susceptibility-weighted imaging.
Ma L; Li J; Azamuddin M; Zheng S; Wang W; Wang P
Magn Reson Imaging; 2022 Oct; 92():26-32. PubMed ID: 35623417
[TBL] [Abstract][Full Text] [Related]
12. [Application of 3.0T MRI 3D-VIBE dynamic contrast-enhanced in the diagnosis of small hepatocellular carcinomas].
Wang CS; Duan Q; Xue YJ
Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):905-8. PubMed ID: 19105934
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses.
Sehgal V; Delproposto Z; Haddar D; Haacke EM; Sloan AE; Zamorano LJ; Barger G; Hu J; Xu Y; Prabhakaran KP; Elangovan IR; Neelavalli J; Reichenbach JR
J Magn Reson Imaging; 2006 Jul; 24(1):41-51. PubMed ID: 16755540
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance susceptibility weighted imaging in detecting intracranial calcification and hemorrhage.
Zhu WZ; Qi JP; Zhan CJ; Shu HG; Zhang L; Wang CY; Xia LM; Hu JW; Feng DY
Chin Med J (Engl); 2008 Oct; 121(20):2021-5. PubMed ID: 19080268
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatocellular carcinoma by ferucarbotran-enhanced magnetic resonance imaging: the efficacy of accumulation phase fat-suppressed T1-weighted imaging.
Chou CT; Chen RC; Chen WT; Lii JM
Clin Radiol; 2009 Jan; 64(1):22-9. PubMed ID: 19070694
[TBL] [Abstract][Full Text] [Related]
17. The use of T2*-weighted multi-echo GRE imaging as a novel method to diagnose hepatocellular carcinoma compared with gadolinium-enhanced MRI: a feasibility study.
Hardie AD; Romano PB
Magn Reson Imaging; 2010 Feb; 28(2):281-5. PubMed ID: 20071122
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility-weighted imaging in grading brain astrocytomas.
Li C; Ai B; Li Y; Qi H; Wu L
Eur J Radiol; 2010 Jul; 75(1):e81-5. PubMed ID: 19726149
[TBL] [Abstract][Full Text] [Related]
19. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
Nishie A; Tajima T; Ishigami K; Ushijima Y; Okamoto D; Hirakawa M; Nishihara Y; Taketomi A; Hatakenaka M; Irie H; Yoshimitsu K; Honda H
J Magn Reson Imaging; 2010 Feb; 31(2):373-82. PubMed ID: 20099351
[TBL] [Abstract][Full Text] [Related]
20. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
Hardie AD; Kizziah MK; Rissing MS
J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
